Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$115.82

-0.37 (-0.32%)

08:02
04/21/17
04/21
08:02
04/21/17
08:02

GW Pharmaceuticals initiated with a Buy at Maxim

Maxim analyst Lauren Chung initiated GW Pharmaceuticals with a Buy rating and $135 price target, calling the company the "market leader" in cannabis therapeutics with a first-mover advantage in epilepsy.

GWPH GW Pharmaceuticals
$115.82

-0.37 (-0.32%)

12/05/16
CANT
12/05/16
NO CHANGE
Target $208
CANT
Buy
GW Pharmaceuticals price target raised after Epidiolex data at Cantor
Cantor analyst Elemer Piros raised his price target for GW Pharmaceuticals to $208 from $182 following its Epidiolex data presented at the American Epilepsy Society meeting. The analyst believes the data illustrates "robustness and remarkable consistency" across two distinct forms of epilepsy, Lennox Gastaut and Dravet syndrome and notes that the company laid to rest the largely overblown concern regarding drug interaction with clobazam. Piros believes GW Pharmaceuticals is in "good shape" for a New Drug Application covering both indications by the end of 1H17, and reiterates a Buy rating on the shares.
02/07/17
CANT
02/07/17
NO CHANGE
Target $208
CANT
Overweight
GW Pharmaceuticals Phase 2 data 'very encouraging,' says Cantor
Cantor Fitzgerald analyst Elemer Piros believes GW Pharmaceuticals' Phase 2 glioblastoma multiforme data today are "very encouraging" and further support of the "multi-potent effect of cannabinoid-based medicines across an array of neurological condition." The analyst reiterates a Buy rating on GW shares with a $208 price target. The stock in early trading is up 93c to $121.69.
02/07/17
PIPR
02/07/17
NO CHANGE
Target $147
PIPR
Overweight
Piper says GW Pharmaceuticals remains on track with Epidiolex
Piper Jaffray analyst Joshua Schimmer said GW Pharmaceuticals remains on track to potentially launch Epidiolex for Dravet Syndrome and LGS in the first half of 2018 and he sees the company's expanded access program and ongoing trials positioning the product for a "robust launch" upon approval. Retention of patients on therapy remains "exceptionally high," added the analyst, who calls GW a top mid-cap pick citing his confidence in the commercial outlook for Epidiolex and optimism about its pipeline. Schimmer keeps an Overweight rating and $147 price target on GW Pharma shares.
03/02/17
JANY
03/02/17
NO CHANGE
Target $55
JANY
Sell
GW Pharmaceuticals expectations, valuation remain too high, says Janney Capital
Janney Capital analyst Ken Trbovich raised his estimates for GW Pharmaceuticals and increased his fair value estimate for the shares to $55, citing the "excitement" he heard among physicians who regularly treat patients with Epidiolex during the Annual Epilepsy Society meeting last December. However, he continues to think regulatory and commercial challenges will likely prevent Epidiolex from achieving high expectations set by the market, even if the drug is approved on first review for Dravet Syndrome and LGS and the subsequent studies in infantile spasm and tuberous sclerosis succeed. Trbovich, who notes that consensus estimates call for Epidiolex to hit $900M in sales in just 3-4 years even though the most recent FDA-approved drugs for orphan epilepsy indications had sales in the range of $100M-$300M 4-8 years after launch, keeps a Sell rating on GW shares.

TODAY'S FREE FLY STORIES

FB

Facebook

$179.37

-8.4 (-4.47%)

, SNAP

Snap

$13.53

-0.585 (-4.15%)

10:41
01/16/18
01/16
10:41
01/16/18
10:41
Conference/Events
FBN Securities media analysts to hold a group luncheon »

Analysts host a Group…

FB

Facebook

$179.37

-8.4 (-4.47%)

SNAP

Snap

$13.53

-0.585 (-4.15%)

TWTR

Twitter

$24.96

-0.455 (-1.79%)

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

LNKD

Acquired by MSFT

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 18

    Mar

GE

General Electric

$18.14

-0.625 (-3.33%)

10:40
01/16/18
01/16
10:40
01/16/18
10:40
Periodicals
GE seen as likely to embrace company breakup, CNBC reports »

General Electric is seen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

HMNY

Helios and Matheson

$7.64

-0.42 (-5.21%)

10:40
01/16/18
01/16
10:40
01/16/18
10:40
Hot Stocks
MoviePass names Natasha Mulla CMO »

MoviePass, movie-theater…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$49.79

0.275 (0.56%)

10:40
01/16/18
01/16
10:40
01/16/18
10:40
Options
Notable interest in iShares Emerging Markets Fund options »

Notable interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$77.54

0.695 (0.90%)

10:38
01/16/18
01/16
10:38
01/16/18
10:38
Hot Stocks
Citi CFO says U.S. Retail Services growing slightly above outlook »

CFO John Gerspach said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

VPG

Vishay Precision

$27.30

0.55 (2.06%)

10:38
01/16/18
01/16
10:38
01/16/18
10:38
Conference/Events
Vishay Precision management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

  • 29

    Mar

SITE

SiteOne Landscape

$71.28

-0.2 (-0.28%)

10:37
01/16/18
01/16
10:37
01/16/18
10:37
Conference/Events
SiteOne Landscape management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

IWM

iShares Trust Russell 2000 Index Fund

$159.21

1.05 (0.66%)

, RUT

Russell 2000 Index

10:36
01/16/18
01/16
10:36
01/16/18
10:36
Technical Analysis
Technical View: Russell 2000 Index crosses above 1600, new life high »

The Russell 2000 (RUT)…

IWM

iShares Trust Russell 2000 Index Fund

$159.21

1.05 (0.66%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTH

LightPath

$2.42

0.09 (3.86%)

10:36
01/16/18
01/16
10:36
01/16/18
10:36
Conference/Events
LightPath management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

LOW

Lowe's

$104.00

3.14 (3.11%)

10:35
01/16/18
01/16
10:35
01/16/18
10:35
Conference/Events
Lowe's management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

GE

General Electric

$18.17

-0.595 (-3.17%)

10:35
01/16/18
01/16
10:35
01/16/18
10:35
Periodicals
GE breakup likely, announcement may come this Spring, CNBC reports »

CNBC's David Faber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

C

Citi

$77.56

0.715 (0.93%)

10:33
01/16/18
01/16
10:33
01/16/18
10:33
Hot Stocks
Breaking Hot Stocks news story on Citi »

Citi CFO: Trading-related…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

10:33
01/16/18
01/16
10:33
01/16/18
10:33
Conference/Events
UBS leisure analyst holds an analyst/industry conference call »

Leisure Analyst Farley…

ITRN

Ituran

$35.30

1.25 (3.67%)

10:33
01/16/18
01/16
10:33
01/16/18
10:33
Conference/Events
Ituran management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

  • 17

    Jan

C

Citi

$77.50

0.66 (0.86%)

10:33
01/16/18
01/16
10:33
01/16/18
10:33
Hot Stocks
Breaking Hot Stocks news story on Citi »

Citi sees core accrual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

AXTA

Axalta Coating

$31.99

-0.45 (-1.39%)

, UBS

UBS

$19.62

0.03 (0.15%)

10:32
01/16/18
01/16
10:32
01/16/18
10:32
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

AXTA

Axalta Coating

$31.99

-0.45 (-1.39%)

UBS

UBS

$19.62

0.03 (0.15%)

CS

Credit Suisse

$19.04

0.08 (0.42%)

NTR

Nutrien

$53.31

-0.12 (-0.22%)

CBM

Cambrex

$52.80

1.15 (2.23%)

DRNA

Dicerna

$8.42

-0.01 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

UA

Under Armour; also tag UAA

$13.13

-1.01 (-7.14%)

, UAA

Under Armour; also tag UA

$14.21

-0.91 (-6.02%)

10:32
01/16/18
01/16
10:32
01/16/18
10:32
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

UA

Under Armour; also tag UAA

$13.13

-1.01 (-7.14%)

UAA

Under Armour; also tag UA

$14.21

-0.91 (-6.02%)

VZ

Verizon

$51.84

-0.023 (-0.04%)

LMT

Lockheed Martin

$336.31

0.06 (0.02%)

COL

Rockwell Collins

$138.14

0.31 (0.22%)

SAVE

Spirit Airlines

$47.19

-1.07 (-2.22%)

FNSR

Finisar

$22.74

0.48 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 21

    Feb

  • 07

    Mar

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

, TWTR

Twitter

$24.88

-0.535 (-2.11%)

10:32
01/16/18
01/16
10:32
01/16/18
10:32
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

TWTR

Twitter

$24.88

-0.535 (-2.11%)

PG

Procter & Gamble

$90.31

0.7 (0.78%)

NOC

Northrop Grumman

$317.94

2.79 (0.89%)

CW

Curtiss-Wright

$133.63

4.893 (3.80%)

ADTN

Adtran

CIEN

Ciena

$22.69

0.75 (3.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 21

    Feb

  • 22

    Feb

  • 06

    Mar

TWTR

Twitter

$24.85

-0.565 (-2.22%)

10:32
01/16/18
01/16
10:32
01/16/18
10:32
Periodicals
Greenlight took 'small' stake in Twitter in Q4, Bloomberg reports »

Bloomberg cites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

XLF

Financial Select Sector

$29.38

0.15 (0.51%)

10:30
01/16/18
01/16
10:30
01/16/18
10:30
Options
Notable spread in SPDR Financials as the sector sees strength »

Notable spread in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:29
01/16/18
01/16
10:29
01/16/18
10:29
Conference/Events
UBS automotive analyst holds an analyst/industry conference call »

Automotive Analyst Hummel…

10:28
01/16/18
01/16
10:28
01/16/18
10:28
General news
Tax reform optimism, Merck help push Dow up 1% to over 26,000 »

Stock futures were strong…

C

Citi

$77.60

0.76 (0.99%)

10:27
01/16/18
01/16
10:27
01/16/18
10:27
Hot Stocks
Citi CFO sees branded-cards NCL rate rising to 300bps in 2018 »

Says adjusting strategy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

CF

CF Industries

$41.63

-1.8919 (-4.35%)

10:26
01/16/18
01/16
10:26
01/16/18
10:26
Technical Analysis
Technical View: CF Industries falls sharply to session lows »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
01/16/18
01/16
10:25
01/16/18
10:25
General news
U.S. corporate bond update: moderate issuance is expected »

U.S. corporate bond…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.